DEUTSCHE BANK AG\ - ARALEZ PHARMACEUTICALS INC ownership

ARALEZ PHARMACEUTICALS INC's ticker is ARLZ and the CUSIP is 03852X100. A total of 47 filers reported holding ARALEZ PHARMACEUTICALS INC in Q2 2018. The put-call ratio across all filers is 1.20 and the average weighting 0.0%.

Quarter-by-quarter ownership
DEUTSCHE BANK AG\ ownership history of ARALEZ PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2018$196,000
-53.4%
563,090
+100.0%
0.00%
Q1 2018$421,000
-19.7%
281,545
-24.0%
0.00%
Q4 2017$524,000
-64.5%
370,245
-42.6%
0.00%
-100.0%
Q3 2017$1,476,000
+55.2%
644,760
-8.6%
0.00%0.0%
Q2 2017$951,000
-6.9%
705,207
+47.5%
0.00%0.0%
Q1 2017$1,022,000
-18.0%
478,180
+69.2%
0.00%0.0%
Q4 2016$1,246,000
-13.5%
282,681
-4.9%
0.00%0.0%
Q3 2016$1,441,000
-10.6%
297,330
-39.2%
0.00%0.0%
Q2 2016$1,612,000
+38.7%
488,992
+48.9%
0.00%0.0%
Q1 2016$1,162,000328,3700.00%
Other shareholders
ARALEZ PHARMACEUTICALS INC shareholders Q2 2018
NameSharesValueWeighting ↓
Rubric Capital Management, LLC 237,547$843,00013.09%
JW Asset Management, LLC 1,836,375$6,519,0004.26%
DRILL CRAIG A 339,300$1,205,0003.04%
Tiger Legatus Capital Management, LLC 1,275,000$4,526,0001.80%
Broadfin Capital, LLC 3,800,000$13,490,0001.30%
Healthcare Value Capital, LLC 175,000$621,0000.91%
Kavi Asset Management, LP 313,627$1,113,0000.87%
Healthcare Value Capital, LLC 100,000$355,0000.52%
Elk Creek Partners, LLC 1,392,746$4,944,0000.37%
Par Capital Management 5,365,000$19,046,0000.30%
View complete list of ARALEZ PHARMACEUTICALS INC shareholders